MPEP 2400
Biotechnology
This is the Ninth Edition of the MPEP, Revision 01.2024, Last Revised in November 2024
Chapter 2400: Biotechnology
2401: Introduction
2402: The Deposit Rules
2403: Deposit of Biological Material
2403.01: Material Capable of Self- Replication
2403.02: Plant Material
2404: Need or Opportunity to Make a Deposit
2404.01: Biological Material That Is Known and Readily Available to the Public
2404.02: Biological Material That Can Be Made or Isolated Without Undue Experimentation
2404.03: Reference to a Deposit in the Specification
2405: Acceptable Depository
2406: Time of Making an Original Deposit
2406.01: Description in Application Specification
2406.02: Deposit After Filing Date - Corroboration
2406.03: Possible Loss of U.S. Filing Date in Other Countries
2407: Replacement or Supplement of Deposit
2407.01: In a Pending Application
2407.02: After a Patent Has Issued
2407.03: Failure to Replace
2407.04: Treatment of Replacement
2407.05: Exemption From Replacement
2407.06: Replacement May Not Be Recognized
2408: Term of Deposit
2409: Viability of Deposit
2410: Furnishing of Samples
2410.01: Conditions of Deposit
2410.02: Certification of Statement of Availability of Deposit
2411: Examination Procedures
2411.01: Rejections Based on Deposit Issue
2411.02: Replies to Rejections Based on Deposit Issue
2411.03: Application in Condition for Allowance Except for Deposit
2411.04: Reserved
2411.05: Content of Application with Respect to Deposited Material
2412: The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures to Include a Sequence Listing in XML file format
2412.01: Overview of the Sequence Rules
2412.02: Definition of "Sequence Listing XML"
2412.02(a): "Enumeration of its residues"
2412.03: Nucleotides and Amino Acids Included and Excluded From a "Sequence Listing XML"
2412.03(a): "Specifically Defined"
2412.03(b): "Amino Acid"
2412.03(c): "Modified Amino Acid"
2412.03(d): "Nucleotide"
2412.03(e): "Modified Nucleotide"
2412.04: Use of Sequence Identifiers to Denote Sequences Disclosed in the Description, Drawings or Claims
2412.05: Representation and Symbols for Nucleotide and/or Amino Acid Sequences
2412.05(a): Use of Sequentially Numbered Sequence Identifiers in the "Sequence Listing XML"
2412.05(b): Representation and Symbols of Nucleotide Sequence Data
2412.05(c): Representation and Inclusion of Variants
2412.05(d): Representation and Symbols of Amino Acid Sequence Data
2412.05(e): Presentation of Special Situations
2412.06: The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
2412.07: Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
2413: Content of a "Sequence Listing XML" and Form and Format of the "Sequence Listing XML" File
2413.01: Parts of the "Sequence Listing XML"
2413.01(a): The "Sequence Listing XML" is a Single File Encoded Using Unicode UTF-8
2413.01(b): The "Sequence Listing XML" Must Be Valid According To the DTD
2413.01(c): The "Sequence Listing XML" Must Contain an XML Declaration
2413.01(d): The "Sequence Listing XML" Must Contain a DOCTYPE Declaration
2413.01(e): The "Sequence Listing XML" Must Contain a Root Element
2413.01(f): The "Sequence Listing XML" Must Contain a General Information Part
2413.01(g): The "Sequence Listing XML" Must Contain a Sequence Data Part
2413.01(h): Language Dependent Free Text Qualifier Values in the English Language
2413.01(i): Title Element in "Sequence Listing XML"
2413.02: Form and Format of the XML file containing the "Sequence Listing XML"
2413.03: How to Submit the "Sequence Listing XML"
2413.04: Requirements Regarding Incorporation By Reference of the "Sequence Listing XML"
2413.05: Presumptions Regarding Compliance
2414: Notification of a Failure to Comply with Sequence Listing Requirements and Amendments Relating to "Sequence Listing XML" Files Under 37 CFR 1.835
2414.01: Issuance of a Notice Relating to the Requirements For Patent Applications Containing Nucleotide and/or Amino Acid Sequence Disclosures
2414.02: Amendment to Add an Initial "Sequence Listing XML" under 37 CFR 1.835(a)
2414.03: Amendment Adding to, Deleting from, or Replacing Sequence Information in a "Sequence Listing XML" under 37 CFR 1.835(b)
2414.04: Translation of "Sequence Listing XML" is Not an Amended "Sequence Listing XML" under 37 CFR 1.835(b)
2414.05: Notifications for Failure to Submit a "Sequence Listing XML" in an International Application under the PCT to be Searched by the United States International Searching Authority or Examined by International Preliminary Examination Authority
2414.06: Amendment of a "Sequence Listing XML" in a Patent
2415: Applicability date of "Sequence Listing XML" Requirements to Applications Based on Filing Date of Application and Procedures for Failure to Submit Correct Format of Sequence Listing
2415.01: Determining if a "Sequence Listing XML" Must be Submitted
2415.02: Provisional Applications Containing Disclosures of Nucleotides and/or Amino Acids, Compliance with 37 CFR 1.831-1.834
2415.03: Improper Submissions of "Sequence Listing" under 1.821(c) When a "Sequence Listing XML" was Required
2416: Form Paragraphs
2417: Helpful Hints for Sequence Rules Compliance under WIPO Standard ST.26
2418: WIPO Sequence Tool
2419: Publishing of Patent Grants and Patent Application Publications with a "Sequence Listing XML"
2419.01: Patent Grants and Patent Application Publications Containing a Non-Lengthy "Sequence Listing XML"
2419.02: Patent Grants and Patent Application Publications Containing a Lengthy "Sequence Listing XML"
2419.03: Patent Grants and Patent Application Publications Containing a "Sequence Listing XML" of 1GB or Larger
2420: The Requirements for Patent Applications Containing Nucleotide Sequence and/or Amino Acid Sequence Disclosures under World Intellectual Property Office Standard ST.25 (WIPO ST.25) - the Sequence Rules
2421: Overview of the Sequence Rules under WIPO ST.25
2421.01: Definition of "Sequence Listing" and Computer Readable Form (CRF)
2421.02: Summary of the Requirements of the Sequence Rules
2421.03: Notification of a Failure to Comply
2421.04: Reserved
2422: Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
2422.01: Nucleotide and/or Amino Acids Disclosures Requiring a "Sequence Listing"
2422.02: The Requirement for Exclusive Conformance; Sequences Presented in Drawing Figures
2422.03: Sequence Listing Submission
2422.03(a): "Sequence Listing" Submitted as ASCII Plain Text Files
2422.04: The Requirement for a Computer Readable Copy of the "Sequence Listing"
2422.05: Reserved
2422.06: Requirement for Statement Regarding Information Contained in the "Sequence Listing" and Separate Computer Readable Form
2422.07: Requirements for Compliance and Consequences of Non-Compliance
2422.08: Presumptions Regarding Compliance
2422.09: Reserved
2423: Symbols and Format To Be Used for Nucleotide and/or Amino Acid Sequence Data for WIPO ST.25
2423.01: Format and Symbols To Be Used in a "Sequence Listing"
2423.02: Depiction of Coding Regions
2423.03: Presentation and Numbering of Sequences
2424: Requirements for Content of a "Sequence Listing" Part of the Specification under WIPO ST.25
2424.01: Informational Requirements for the "Sequence Listing"
2424.02: "Sequence Listing" Numeric Identifiers
2424.03: Additional Miscellaneous Requirements
2425: Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25
2426: Amendments to Add or Replace a "Sequence Listing" and CRF Copy Thereof Subject to WIPO ST. 25
2427: Form Paragraphs for Applications Subject to WIPO ST.25
2428: Sample Statements under WIPO ST.25
2429: Helpful Hints for Sequence Rules Compliance under WIPO ST.25
2430: PatentIn Information
2431: Sample "Sequence Listing" under WIPO ST.25
2432: Reserved
2433: Box Sequence; Hand Delivery of a "Sequence Listing" and Computer Readable Forms
2434: Examination of Patent Applications Claiming Large Numbers of Nucleotide Sequences
2435: Publishing of Patents and Patent Application Publications with a Lengthy "Sequence Listing"